Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross...
Main Authors: | Khushbu Khetan, Ranjit K Sahoo, Vandana Baloda, Shalimar, Sreenivas Vishnubhatla, Anoop Saraya, Nihar Ranjan Dash, Atul Sharma, Siddhartha DattaGupta, Prasenjit Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2021;volume=64;issue=5;spage=160;epage=165;aulast=Khetan |
Similar Items
-
Effects of Expression of ERCC1, RRM1 on Survival Trend of Lung Cancer with Cisplatin Combine Gemcitabine Chemotherapy after Surgical Resection
by: Min SONG, et al.
Published: (2009-05-01) -
Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer
by: Lina Carvalho, et al.
Published: (2009-08-01) -
A study on the relationship between RRM1 single nucleotide polymorphisms and clinical characteristics in lung cancer patients
by: Li LIN, et al.
Published: (2008-12-01) -
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
by: Pei-Ming Yang, et al.
Published: (2020-01-01) -
Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer
by: Jiawei TIAN, et al.
Published: (2015-06-01)